ATE374369T1 - Verfahren zur erkennung von regulatoren des zellzyklus - Google Patents

Verfahren zur erkennung von regulatoren des zellzyklus

Info

Publication number
ATE374369T1
ATE374369T1 AT98909637T AT98909637T ATE374369T1 AT E374369 T1 ATE374369 T1 AT E374369T1 AT 98909637 T AT98909637 T AT 98909637T AT 98909637 T AT98909637 T AT 98909637T AT E374369 T1 ATE374369 T1 AT E374369T1
Authority
AT
Austria
Prior art keywords
homologue
derivative
substance
components
cell cycle
Prior art date
Application number
AT98909637T
Other languages
English (en)
Inventor
Susanne Brown
Alasdair Maclean
June Harland
Original Assignee
Crusade Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9705299.7A external-priority patent/GB9705299D0/en
Priority claimed from GBGB9719919.4A external-priority patent/GB9719919D0/en
Application filed by Crusade Lab Ltd filed Critical Crusade Lab Ltd
Application granted granted Critical
Publication of ATE374369T1 publication Critical patent/ATE374369T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • G01N2333/4704Inhibitors; Supressors
AT98909637T 1997-03-14 1998-03-16 Verfahren zur erkennung von regulatoren des zellzyklus ATE374369T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9705299.7A GB9705299D0 (en) 1997-03-14 1997-03-14 Methods for identifying cell cycle regulators
GBGB9719919.4A GB9719919D0 (en) 1997-09-18 1997-09-18 Methods for identifying cell cycle regulators

Publications (1)

Publication Number Publication Date
ATE374369T1 true ATE374369T1 (de) 2007-10-15

Family

ID=26311184

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98909637T ATE374369T1 (de) 1997-03-14 1998-03-16 Verfahren zur erkennung von regulatoren des zellzyklus

Country Status (6)

Country Link
US (2) US6235467B1 (de)
EP (1) EP0975972B1 (de)
AT (1) ATE374369T1 (de)
AU (1) AU6412098A (de)
DE (1) DE69838478T2 (de)
WO (1) WO1998041873A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387658B1 (en) * 1999-09-23 2002-05-14 Rigel Pharmaceuticals, Inc. PCNA-associated cell cycle proteins, compositions and methods of use
GB0020067D0 (en) * 2000-08-16 2000-10-04 Univ Glasgow Treatment of cerebral ischaemic damage
GB0203285D0 (en) 2002-02-12 2002-03-27 Brown Susanne M An herpes simplex virus complex
US7097996B2 (en) * 2002-09-06 2006-08-29 New York University Methods of screening test compounds using GADD34L, an eIF2α-specific phosphatase subunit
GB0228788D0 (en) * 2002-12-10 2003-01-15 Univ Glasgow Materials and methods relating to herpes simplex virus protein complexes
US20040229211A1 (en) * 2003-05-13 2004-11-18 Yeung Wah Hin Alex Sensitive diagnostic testing methodology using multiplex real time PCR with one dye (MOD) and its use as in severe acute respiratory syndrome (SARS)
GB0408103D0 (en) * 2004-04-08 2004-05-12 Crusade Lab Ltd Novel herpes simplex viruses
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
US9209634B2 (en) 2012-09-07 2015-12-08 Greatbatch Ltd. Method of improving battery recharge efficiency by statistical analysis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG43035A1 (en) 1994-08-04 1997-10-17 British Telecomm In-service monitoring in communication networks
GB9422175D0 (en) * 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
GB9509557D0 (en) 1995-05-11 1995-07-05 Univ Dundee PCNA binding substance
US5834216A (en) * 1995-09-06 1998-11-10 Arch Development Corporation Screening methods for the identification of inducers and inhibitors of programmed cell death (apoptosis)
AU6964596A (en) 1995-09-11 1997-04-01 Arch Development Corporation Materials and methods for treating neurodegenerative diseases and for screening for candidate apoptosis inhibitors and inducers
GB9615794D0 (en) * 1996-07-26 1996-09-04 Medical Res Council Mutant herpes simplex virus strains and uses thereof

Also Published As

Publication number Publication date
WO1998041873A1 (en) 1998-09-24
DE69838478D1 (de) 2007-11-08
US20010001058A1 (en) 2001-05-10
US6641995B2 (en) 2003-11-04
EP0975972A1 (de) 2000-02-02
AU6412098A (en) 1998-10-12
EP0975972B1 (de) 2007-09-26
DE69838478T2 (de) 2008-06-26
US6235467B1 (en) 2001-05-22

Similar Documents

Publication Publication Date Title
ATE357663T1 (de) Teilchenförmiges markierungsmittel verwendendes analytassay
DK0779984T3 (da) Optisk læsbar strimmel til analytpåvisning med en standard på strimlen
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
ATE430923T1 (de) Vorrichtung zur klassifikation von geflügeleiern
ES8407209A1 (es) Un metodo para determinar sitios insaturados de proteinas que se unen a tiroxina en una muestra que contiene proteinas que se unen a tiroxina
DE69838478D1 (de) Verfahren zur Erkennung von Regulatoren des Zellzyklus
IL112146A0 (en) Test device and method for the detection of protein in a biological sample
DE59107797D1 (de) Verfahren zum Nachweis von phosphoryliertes Tyrosin enthaltenden Proteinen
DK124083A (da) Homogen immunobestemmelsesmetode til bestemmelse af en analyt i en testproeve, reagenspraeparat og -system til anvendelse ved bestemmelsen samt fremgangsmaade til fremstilling af et reagens til anvendelse ved bestemmelsen
EP0125893A3 (de) Quantitative Bestimmung von Antigenen durch Enzym-Antikörper-Brückenverfahren
EP0672062A4 (de) Eine petroleum immuntestmethode, ihre komponenten und kit für deren anwendung.
DE69121861D1 (de) Peptide von sm-d-antigen, deren benützung zum nachweis von disseminierten lupus-erythemateux
DK568684D0 (da) Specifik bindingsbestemmelsesmetode til bestemmelse af en analyt i en testproeve samt reagenssystem til anvendelse ved metoden
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
ATE247831T1 (de) Verfahren zum nachweis von autoimmun-pathologien
DE69407051T2 (de) Nachweis hitzestabiler proteine aus fleisch von wiederkäuern
Alhanaty et al. Monitoring the resolution of proteins and peptides in the course of their electrophoresis: Use in studying the degradative inactivation of cAMP‐dependent protein kinase
SE9300231D0 (sv) Foerbaettrad metod foer brytningsindexdetektion i vaetska
ATE269971T1 (de) Verfahren zur prüfung von immunokompetenz
TW373070B (en) Analysis element and method for preparing the same
DK541883A (da) Fremgangsmaade til paavisning af sle antistoffer i serum samt liposompraeparat til anvendelse herved
Turina Principles of Some Systems for Identification and Characterization of Engineering Materials
Stadthaus et al. Research on Recognition of Magnetic Particle and Liquid Penetrant Indications With an Image Processing System
IT9006603A1 (it) Test immunoenzimatico classe specifico per la ricerca e determinazione degli anticorpi anti-cardiolipina nel siero.
TW326449B (en) Nitro or nitroso substituted polyhalogenated phenolsulfonephthaleins and analytical test strips and methods for the detection of protein in a biological sample using same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975972

Country of ref document: EP

REN Ceased due to non-payment of the annual fee